Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medica SurB de CVMSURF 81 Debt-to-Equity is 0.40 as of Dec. 2025, which is at its 10-year median of 0.40. GuruFocus rates MSURF with a GF Score™ of 81/100 and a GF Value™ of $0.53. The stock has 5 warning signs investors should review. Among 557 Healthcare Providers & Services companies, Medica SurB de CV ranks better than 50.45% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Medica SurB de CV's Debt-to-Equity or its related term are showing as below:
MSURF'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.4 Max: 0.51
Current: 0.4
During the past 13 years, the highest Debt-to-Equity Ratio of Medica SurB de CV was 0.51. The lowest was 0.01. And the median was 0.40.
MSURF's Debt-to-Equity is ranked better than 50.45% of 557
companies
in the Healthcare Providers & Services industry
Industry Median: 0.41
vs MSURF: 0.40
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Medica SurB de CV Debt-to-Equity Related Terms
Medica SurB de CV Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Medica SurB de CV's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Medica SurB de CV's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medica SurB de CV Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medica SurB de CV's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Medica SurB de CV's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medica SurB de CV (MSURF) has a Debt-to-Equity of 0.40 as of Dec. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Medica SurB de CV and its competitors. This is near median its historical median of 0.40. Over the past decade, Medica SurB de CV's Debt-to-Equity has ranged from 0.01 to 0.51. According to the industry distribution chart, Medica SurB de CV ranks #276 out of 557 companies in the Healthcare Providers & Services industry, placing it in the top 49.6%.
Is Medica SurB de CV's Debt-to-Equity too high?
Medica SurB de CV's current Debt-to-Equity of 0.40 is near median its 10-year median of 0.40. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 0.51. The Healthcare Providers & Services industry median Debt-to-Equity is 0.41. Medica SurB de CV's value of 0.40 is 2.4% below this industry median. Based on the distribution chart, Medica SurB de CV ranks #276 out of 557 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Medica SurB de CV has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Medica SurB de CV's Debt-to-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medica SurB de CV ranks #276 out of 557 companies for Debt-to-Equity. This puts Medica SurB de CV in the upper half of its industry. The industry median Debt-to-Equity is 0.41. Medica SurB de CV's value of 0.40 is 2.4% below this benchmark. Historically, Medica SurB de CV's own Debt-to-Equity has ranged from 0.01 to 0.51 over the past decade. While the company's 10-year median is 0.40 vs. the industry median of 0.41, Medica SurB de CV has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.41, based on 557 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medica SurB de CV's current Debt-to-Equity of 0.40 is 2.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Medica SurB de CV and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medica SurB de CV's current Debt-to-Equity is 0.40, which is near median its own 10-year median of 0.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medica SurB de CV stock overvalued right now?
Medica SurB de CV (MSURF) has a current Debt-to-Equity of 0.40. The stock's GF Value™ is $0.53, compared to a current price of $0.67 — trading 27% above its estimated fair value. The current Debt-to-Equity is 0.40, which is near median its 10-year median of 0.40 and 2.4% below the Healthcare Providers & Services industry median of 0.41. Medica SurB de CV's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Medica SurB de CV (MSURF), the current Debt-to-Equity is 0.40 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medica SurB de CV (MSURF) Overvalued in 2026?
Based on GuruFocus' analysis, Medica SurB de CV stock appears to be overvalued.
The current stock price of $0.67 is trading 27% above its estimated GF Value™ of $0.53.
Key valuation signals for MSURF:
Debt-to-Equity: 0.40 (near median its 10-year median of 0.40)
GF Value™: $0.53 vs. price of $0.67 (27% above fair value)
Industry Position: 2.4% below the Healthcare Providers & Services median (#276 of 557)
No single metric tells the full story. See the MSURF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medica Sur SAB de CV is a medical care company specializes in emergency scenarios. The company offers emergency ambulance transportation, air transportation and paramedic assistance.
81GF Score
Get the complete analysis for MSURF
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MSURF has been successfully added to your 
